Galli G, Bagnato A, Galli M
Institute of Nuclear Medicine, Catholic University of Rome, Italy.
Nucl Med Commun. 1995 Sep;16(9):773-8. doi: 10.1097/00006231-199509000-00008.
It is possible to obtain an estimate of the bone uptake of diphosphonates after 3 h (BU) on the basis of the difference between the dose administered and the sum of the component eliminated in the urine plus the component present in the extra-osseous volume of distribution. The results of this simple method have been compared in 15 patients using whole body retention at 24 h (determined by means of a complete urine collection) and the ratio of plasma concentrations of 51Cr-EDTA/99Tcm-HMDP after 3 h (DPS). Both DPS and BU can be used on a practical basis, and therefore be used routinely with scintigraphy. The added advantage is that, for BU, the use of a second radiopharmaceutical is avoided.
基于给药剂量与尿中消除成分之和加上骨外分布容积中存在的成分之间的差异,可以在3小时后获得双膦酸盐骨摄取量(BU)的估计值。已在15名患者中使用24小时全身滞留量(通过收集全部尿液确定)和3小时后51Cr-EDTA/99Tcm-HMDP的血浆浓度比(DPS)对这种简单方法的结果进行了比较。DPS和BU在实际应用中均可行,因此可与闪烁扫描法一起常规使用。额外的优点是,对于BU,无需使用第二种放射性药物。